Stryker RegenKit®-THT Offers Safe and Rapid Preparation of Autologous Platelet-Rich Plasma (A-PRP) (press release)
Stryker Joint Preservation, a business unit of Stryker's Orthopaedics group, today announced at the 2011 American Orthopaedic Society for Sports Medicine meeting that it has entered into an exclusive collaboration with RegenLab SA to distribute Stryker's RegenKit-THT, a one-step system designed for the safe and rapid preparation of autologous platelet-rich plasma (A-PRP) from a small sample of blood at the patient's point of care.
A-PRP contains an increased concentration of platelets, while maintaining physiological levels of leukocytes (white blood cells). When activated, platelets have been found to release growth factors which may participate in the healing process, and a multitude of proteins and bioactive factors critical to the healing process and the recruitment of cells. Leukocytes are responsible primarily for defending the body against infection, but are also key players during the initial inflammation phase of tissue healing.
In comparison to competitive offerings, the A-PRP prepared using Stryker's RegenKit-THT provides the highest platelet recove...
